CN105265985A - Corn stigma solid beverage and preparation method thereof - Google Patents
Corn stigma solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN105265985A CN105265985A CN201510732949.5A CN201510732949A CN105265985A CN 105265985 A CN105265985 A CN 105265985A CN 201510732949 A CN201510732949 A CN 201510732949A CN 105265985 A CN105265985 A CN 105265985A
- Authority
- CN
- China
- Prior art keywords
- corn stigma
- corn
- solid beverage
- silk
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 240000008042 Zea mays Species 0.000 title claims abstract description 116
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title claims abstract description 88
- 235000002017 Zea mays subsp mays Nutrition 0.000 title claims abstract description 88
- 235000005822 corn Nutrition 0.000 title claims abstract description 88
- 239000007787 solid Substances 0.000 title claims abstract description 53
- 235000013361 beverage Nutrition 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 31
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 235000019202 steviosides Nutrition 0.000 claims abstract description 9
- 235000007244 Zea mays Nutrition 0.000 claims description 28
- 229940089639 cornsilk Drugs 0.000 claims description 28
- 239000001231 zea mays silk Substances 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 27
- 239000000843 powder Substances 0.000 claims description 17
- 238000007710 freezing Methods 0.000 claims description 10
- 230000008014 freezing Effects 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- 239000004383 Steviol glycoside Substances 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 229930182488 steviol glycoside Natural products 0.000 claims description 8
- 235000019411 steviol glycoside Nutrition 0.000 claims description 8
- 150000008144 steviol glycosides Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- 239000008103 glucose Substances 0.000 abstract description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 18
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 abstract 1
- 229940013618 stevioside Drugs 0.000 abstract 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 22
- 239000000203 mixture Substances 0.000 description 20
- 235000000346 sugar Nutrition 0.000 description 19
- 230000000694 effects Effects 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 8
- 230000003592 biomimetic effect Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000010903 husk Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 208000002249 Diabetes Complications Diseases 0.000 description 4
- 206010012655 Diabetic complications Diseases 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 238000013103 analytical ultracentrifugation Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- -1 cholesterol triglycerides Chemical class 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011122 softwood Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940018492 plantago seed Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a corn stigma solid beverage and a preparation method thereof. The corn stigma solid beverage is prepared from the following raw materials in parts by weight: 10 to 60 parts of corn stigma extract, 10 to 60 parts of newtol and 10 to 60 parts of stevioside. The invention also discloses the preparation method of the corn stigma solid beverage. The corn stigma solid beverage provided by the invention has the functions of reducing blood glucose, reducing blood fat, diuresis and the like, and unique fragrant taste of corn is kept during dissolving.
Description
Technical field
The present invention relates to solid beverage manufacture field.More specifically, a kind of corn stigma solid beverage and preparation method thereof is related to.
Background technology
The style that corn stigma (stigmamaydis) is grass family beautiful another name for Sichuan Province platymiscium corn and column cap.In China, corn stigma has long clinical application history as Chinese medicine, research shows, containing multiple bioactive ingredients in corn stigma, such as flavones and glycoside thereof, sterol, alkaloid, carbohydrate, organic acid, volatile oil, trace element and multivitamin etc., its extract has the effects such as anti-oxidant, diuresis, hypoglycemic, antibacterial, step-down and enhancing immunity.Food and Drug Administration confirms that corn stigma is as safety, nontoxic material.
In recent years, because of the feature that it safely, is easy to get, the research about corn stigma is had to increase year by year, the also corresponding appearance of various corn stigma goods.Because corn silk water extract has good health-care efficacy, people start the health beverages that exploitation take corn stigma as primary raw material, such as China Patent Publication No. CN101940349A discloses " a kind of corn stigma mineral water and preparation method thereof " and China Patent Publication No. CN1159301A discloses " a kind of plant health-care beverage and manufacture craft thereof ", but these patents all belong to liquid beverage, in transportation, increase cost, carry inconvenience.Corn tassel injection and preparation method thereof disclosed in China Patent Publication No. CN1382484A, but then there is security risks in corn tassel injection, and its production cost is also high compared with other formulations.Therefore, when corn stigma increasing market heat, need to create a kind of safety, product is imperative easily.
Summary of the invention
The object of this invention is to provide a kind of corn stigma solid beverage, this corn stigma solid beverage has the effects such as hypoglycemic, lipopenicillinase and diuresis, and does not add other anticorrisive agent any, has easy to carry, be easy to the advantages such as dissolving, during dissolving, retain the distinctive delicate fragrance taste of original corn.
For achieving the above object, the present invention adopts following technical proposals:
The invention provides a kind of corn stigma solid beverage, this corn stigma solid beverage comprises the raw material of following weight parts: Corn silk P.E (solid type or liquid-type) 10 ~ 60 parts, xylitol 10 ~ 60 parts and steviol glycoside 10 ~ 60 parts.
Preferably, corn stigma solid beverage of the present invention also comprises circle luxuriant Cillium 10 ~ 60 parts.Particularly, the luxuriant isapgol husk of circle is the new raw-food material of one of national health and the bulletin approval of No. 10, Family Planning Committee 2014, these raw material sources seed hull of (Classification system: Plantagoovata) before the luxuriant car of Plantaginaceae Plantago circle of India's artificial growth.Have relax bowel, reducing blood lipid, the effect such as reduction type II diabetes risk and supplementary soluble dietary fiber, be applicable to nutritious supplementary pharmaceutical, solid beverage and bakery etc.The luxuriant isapgol husk of circle in corn stigma solid beverage with Corn silk P.E jointly as raw material, there is reduction blood sugar, prevent and improve diabetic complication effect while, diuresis obviously strengthens.
State on the invention in formula, the effective active that can be extracted in corn stigma by ultrasonic assistant half biomimetic method or heat reflow method becomes to assign to prepare Corn silk P.E.
Particularly, ultrasonic assistant half biomimetic method: take corn stigma, the aqueous solution adding pH7.0 ~ 7.5 of 5 ~ 20 times of corn stigma weight carries out ultrasonic extraction, and the power of ultrasonic extraction is 50 ~ 100w, and the time is 0.5 ~ 3 hour, filter, collect filtrate, gained filter residue uses the ultrasonic extraction of the aqueous solution of pH8.1 ~ 8.5 of 5 ~ 20 times of corn stigma weight 0.5 ~ 3 hour again, filters, merge and extract gained filtrate, obtain liquid-type Corn silk P.E through reduced pressure concentration; Or, further by described liquid-type Corn silk P.E freezing 24 ~ 36h under-100 ~-50 DEG C of conditions, then at-60 ~-48 DEG C, freeze-drying 36 ~ 72h under air pressure 0.05mbar condition, pulverized 60 mesh sieves, obtain freeze-dried powder, obtain solid type Corn silk P.E.
Heat reflow method: take corn stigma, the water heating reflux method adding 5 ~ 20 times of corn stigma weight extracts 2 times, each 1h, merges extract, obtains liquid-type corn stigma extract through reduced pressure concentration; Or, further by described liquid-type corn stigma extract freezing 24 ~ 36h under-100 ~-50 DEG C of conditions, then at-60 ~-48 DEG C, freeze-drying 36 ~ 72h under air pressure 0.05mbar condition, pulverized 60 mesh sieves, obtain freeze-dried powder, obtain solid type Corn silk P.E.
Further, corn stigma described in said method, after the cleaning of fresh corn stigma being dried, to obtain final product.
Present invention also offers the preparation method of above-mentioned corn stigma solid beverage, namely comprise after above-mentioned all raw materials are mixed and make particle.
Beneficial effect of the present invention is as follows:
Corn stigma solid beverage of the present invention keeps the corn flavor enjoying people to like, delicate fragrance is good to eat.In addition corn stigma solid beverage can also add the luxuriant isapgol husk of appropriate circle, have relax bowel, reducing blood lipid, the effect such as reduction type II diabetes risk and supplementary soluble dietary fiber, be applicable to nutritious supplementary pharmaceutical, solid beverage and bakery etc.The luxuriant isapgol husk of circle in corn stigma solid beverage with Corn silk P.E jointly as raw material, have reduction blood sugar, while preventing and improving diabetic complication effect, diuresis significantly strengthens.
We are in the hypoglycemic screening process of each extract of corn stigma (corn silk water extract, alcohol extract and ultrasonic assistant half biomimetic method extract) early stage, find that water extract and ultrasonic assistant half biomimetic method extract hypoglycemic activity are better than other extracting method, the mouse hyperglycemic state of alloxan induction can be improved, and can mice pancreatic be repaired, increase hepatic glycogen content; And the hypoglycemic activity of ultrasonic assistant half biomimetic method extract is more remarkable.The present invention extracts the effective active composition in corn stigma by ultrasonic assistant half biomimetic method, the method prepare freeze-dried powder recovery rate comparatively heating and refluxing extraction legal system improve a lot for freeze-dried powder.
The production technology of corn stigma solid beverage of the present invention is simple, and product is stablized.Corn stigma solid beverage of the present invention maintains the delicate fragrance taste of original corn stigma.This corn stigma solid beverage has reduction blood sugar, while preventing and improving diabetic complication effect, also has obvious diuresis.
Detailed description of the invention
In order to be illustrated more clearly in the present invention, below in conjunction with preferred embodiment, the present invention is described further.It will be appreciated by those skilled in the art that specifically described content is illustrative and nonrestrictive, should not limit the scope of the invention with this below.
Embodiment 1 ultrasonic assistant half biomimetic method prepares Corn silk P.E
After the cleaning of A corn stigma is dried, the aqueous solution adding the pH7.5 of 10 times of corn stigma weight carries out ultrasonic extraction, the power of ultrasonic extraction is 70w, time is 1 hour, filters, and collects filtrate, gained filter residue uses the aqueous solution of the pH8.3 of 10 times of corn stigma weight ultrasonic 1 hour again, filter, merge and extract gained filtrate, obtain liquid-type Corn silk P.E through reduced pressure concentration; This liquid-type Corn silk P.E can as the raw material of its solid beverage of preparation.
B is: gained concentrate freezing 24h at-80 DEG C in steps A, at-48 DEG C, freeze-drying 48h under air pressure 0.05mbar condition after freezing, pulverize 60 mesh sieves, and makes freeze-dried powder; This freeze-dried powder also can as the raw material for preparing its solid beverage.
Embodiment 2 ultrasonic assistant half biomimetic method prepares Corn silk P.E
After the cleaning of A corn stigma is dried, the aqueous solution adding the pH7.0 of 20 times of corn stigma weight carries out ultrasonic extraction, the power of ultrasonic extraction is 100w, time is 0.5 hour, filters, and collects filtrate, gained filter residue uses the aqueous solution of the pH8.1 of 20 times of corn stigma weight ultrasonic 0.5 hour again, filter, merge and extract gained filtrate, obtain liquid-type Corn silk P.E through reduced pressure concentration; This liquid-type Corn silk P.E can as the raw material of its solid beverage of preparation.
B is: gained concentrate freezing 36h at-60 DEG C in steps A, at-60 DEG C, freeze-drying 72h under air pressure 0.05mbar condition after freezing, pulverize 60 mesh sieves, and makes freeze-dried powder; This freeze-dried powder also can as the raw material for preparing its solid beverage.
Embodiment 3 heating reflux method prepares Corn silk P.E
After the cleaning of A corn stigma is dried, corn stigma extracts 2 times with the water heating reflux method of 10 times of weight, each 1h, merges extract, obtains corn stigma extract through reduced pressure concentration; This extract can as the raw material of its solid beverage of preparation.
B is: gained concentrate freezing 24h at-80 DEG C in steps A, at-48 DEG C, freeze-drying 48h under air pressure 0.05mbar condition after freezing, pulverize 60 mesh sieves, and makes freeze-dried powder; This freeze-dried powder also can as the raw material for preparing its solid beverage.
Prepared by embodiment 4 corn stigma solid beverage
(1) Example 1 gained corn stigma freeze-dried powder 40 weight portion, for subsequent use;
(2) get 40 parts by weight Corn palpus freeze-dried powders, 40 weight portion xylitols, 20 weight portion steviol glycosides mixing, directly granulate with dry powder particle machine, obtain corn stigma solid beverage.
Prepared by embodiment 5 corn stigma solid beverage
(1) with embodiment 4 step (1);
(2) get 40 parts by weight Corn palpus freeze-dried powders, the luxuriant Plantago Seed of circle of 20 weight portions, the xylitol of 20 weight portions, 20 weight portion steviol glycosides mixing, directly granulate with dry powder particle machine, obtain corn stigma solid beverage.
Prepared by embodiment 6 corn stigma solid beverage
(1) corn stigma extract 10 weight portion in Example 3 steps A, for subsequent use;
(2) get 10 parts by weight Corn palpus extracts, 30 weight portion xylitols, 10 weight portion steviol glycosides mixing, softwood processed, granulates with oscillating granulator, dry, obtains corn stigma solid beverage.
Prepared by embodiment 7 corn stigma solid beverage
(1) corn stigma extract 60 weight portion in Example 1 steps A, for subsequent use;
(2) get 60 parts by weight Corn palpus extracts, 10 weight portion xylitols, circle luxuriant Cillium 40 parts, 40 weight portion steviol glycosides mixing, softwood processed, granulates with oscillating granulator, dry, obtains corn stigma solid beverage.
Embodiment 8 describes effect of the present invention in detail below by test example
One, hypoglycemic, lipid-lowering test
1 principle
High thermal energy fodder is fed and is raised on basis, is aided with low dose of alloxan, causes sugar/disorders of lipid metabolism, insulin resistance, bring out artificial diabetes.
2 modeling methods
Buy healthy male rat (150 ± 20g), common maintenance material adapts to raising 3 days, fasting 4 hours, get tail blood, measure to (namely 0 hour) blood glucose value before glucose, to 0.5,2 hours blood glucose values after 2.5g/kgBW glucose, as this batch of animal basic value.6 groups are divided, i.e. 1 blank group, 1 model control group, 1 positive drug control group and 3 administration groups with 0,0.5 hours blood glucose level.
Often organize 10.Blank group does not deal with, 3 administration group gavages give different given the test agent, model control group gives different volumes solvent, continuous 33 days, wherein each group gives to maintain material raising and changes high lipid food except blank group place blank group is outer after 1 week, continue hello raise 3 weeks after, fasting 24 hours (can't help water) except blank group, give alloxan 105mg/kgBW lumbar injection, injection volume 1ml/100g body weight.Continue to give high thermal energy fodder after injection to feed and raise 5 days.Off-test, each treated animal fasting 4 hours, detects fasting blood-glucose, sugar tolerance, serum insulin and cholesterol, triglyceride levels.(this method carries out modeling according to health food assessment technique specification 2012 revised edition)
1 model control group (feed, and gives same volume solvent gastric infusion, once a day) by high lipid food;
1 blank group (gives same volume solvent gastric infusion, once a day);
(dose,equivalent of rat is equivalent to 5 times of human body recommended amounts to 1 positive drug control group for melbine, dosage 0.375g/kg, is equivalent to adult human dose 4.5g/ every day, same volume gastric infusion, once a day);
1 administration control group, component is (the luxuriant Cillium of circle), (dosage 0.5g/kg, same volume gastric infusion, once a day);
1 embodiment 4 composition (dosage 0.5g/kg, same volume gastric infusion, once a day).
1 embodiment 5 composition (dosage 0.5g/kg, same volume gastric infusion, once a day).
3 observation index
3.1 fasting blood-glucoses, sugar tolerance
Each treated animal fasting 4 hours (morning 8 is to 12 noon), measure fasting blood sugar namely to (0 hour) blood glucose value before glucose, dosage group gives variable concentrations given the test agent, model control group gives same volume solvent, blank group does not process, each group oral administration of glucose 2.5g/kgBW after 15 ~ 20 minutes, measure to group 0.5 each after glucose, the blood glucose value of 2 hours, if model control group 0.5 hours blood glucose value >=10mmol/L, or model control group 0.5 hour, within 2 hours, arbitrary time point blood sugar raises or Area under the curve of blood glucose rising, compare with blank group, difference has conspicuousness, decision model carbohydrate metabolism disturbance is set up, on this basis, observing and nursing control group is in given the test agent group fasting blood-glucose, to after glucose (0.5, 2 hours) blood sugar and 0, 0.5, the change of 2 hours blood glucose TG-AUCs.
Measurement result in table 1, table 2.
3.2 cholesterol, triglycerides
This sky after drug withdrawal, each treated animal fasting 3 ~ 4 hours, detect serum cholesterol, triglycerides, if model control group cholesterol or the obvious height of triglycerides, compare with blank group, difference has conspicuousness, and decision model disorders of lipid metabolism is set up, on this basis, observing and nursing control group and given the test agent Blood Lipid.Measurement result is in table 3.
3.3 data processings and result judge
General employing variance analysis, but first need carry out homogeneity test of variance by the program of variance analysis, variance is neat, calculate F value, F value < 0.05, conclusion: no significant difference between each group mean: F value >=0.05, P≤0.05, adds up with the comparative approach between two of mean between multiple experimental group and a control group.
4 experimental results
4.1 animal used as test fasting blood sugars, as shown in table 1.
Table 1 animal used as test fasting blood sugar statistical form
| Group | Fasting blood-glucose |
| Blank | 4.90 |
| Positive drug control group | 5.37 |
| Model group | 6.78 |
| The luxuriant Cillium group of circle | 6.12 |
| Embodiment 4 composition group | 5.49# |
| Embodiment 5 composition group | 5.21# |
Note: *: with blank group than P < 0.05, #: with model group than P < 0.05
4.2 carbohydrate tolerance test results, as shown in table 2.
Table 2 carbohydrate tolerance test result statistical form
| Sugar tolerance | 0 | 0.5 | 2 |
| Blank | 3.97 | 5.30 | 4.64 |
| Positive drug control group | 5.34 | 6.43 | 5.98 |
| Model group | 5.12 | 7.68* | 6.45* |
| The luxuriant Cillium group of circle | 5.26 | 7.59 | 6.03 |
| Embodiment 4 composition group | 4.68 | 7.01 | 5.96 |
| Embodiment 5 composition group | 5.05 | 7.10 | 5.83# |
Note: *: with blank group than P < 0.05, #: with model group than P < 0.05
4.3 T-CHOL triglyceride determination results, as shown in table 3.
Table 3 T-CHOL triglyceride determination result statistical form
| Group | T-CHOL | Triglycerides |
| Blank | 2.35 | 0.49 |
| Positive drug control group | 2.96 | 0.98 |
| Model group | 3.57 | 1.49* |
| The luxuriant Cillium group of circle | 3.24 | 0.87# |
| Embodiment 4 composition group | 2.84# | 0.75# |
| Embodiment 5 composition group | 2.73# | 0.71# |
Note: *: with blank group than P < 0.05, #: with model group than P < 0.05
By fasting blood sugar, sugar tolerance, the measurement results such as cholesterol triglycerides can be found out, in fasting blood sugar, embodiment 4 composition group has significant difference in model group than all, and embodiment 5 composition group compares in significant difference in model group; In carbohydrate tolerance test result, model group contrasts with blank group, 0.5h and 2h blood glucose value significantly raises, and embodiment 5 composition group and model group contrast, and significantly decline at 2h blood glucose value, points out this solid beverage to have certain effect at delay postprandial hyperglycemia tool.In the measurement result of cholesterol triglycerides, model group is organized with blank and is contrasted T-CHOL, content of triglyceride significantly rises, embodiment 5 composition group and model group contrast T-CHOL, content of triglyceride significantly declines, have statistical significance, comprehensive above experimental result, embodiment 5 composition group is in fasting blood-glucose, sugar tolerance, AUC, the result of cholesterol is all positive, has positive effect.
The solid beverage that the present invention is prepared into Corn silk P.E, can effectively reach reduction blood sugar, prevent and improve the effect of diabetic complication, and taking convenience, safe and effective, can long-term use and have small side effects, is the health products that diabetic is desirable.
Two, diuresis experiment
Wister rat (SPF, 160 ± 10g, ♂ ♀ half and half) 60, be divided at random 5 groups (♂ ♀ half and half), all with 40mL/kg administration capacity gavage physiological saline respectively before experiment, then blank does not deal with, the other administration of positive control, formulation components; Frusemide dosage is 2.0mg/kg, the luxuriant isapgol husk of circle, embodiment 4 composition, embodiment 5 composition dosage are 0.5g/kg.Rat is placed in metabolic cage, collects 0 ~ 1 respectively, urine in 1 ~ 2,2 ~ 3,3 ~ 4,4 ~ 5h each time periods, record volume of urine, as shown in table 4.
Table 4 rat urine volume statistical form
The solid beverage that the present invention is prepared into Corn silk P.E, after composition adds the luxuriant Cillium of circle, the urine volume of rat, embodiment 5 composition group has significant difference in normal group, and diuresis significantly strengthens.
Toxicological experiment:
Acute toxicity test: mouse, rat limosis gavage product of the present invention, observe 7 days, male and female Mouse and rat is showed no poisoning symptom, without dead, the nontoxic level in true border.
Product A mes test of the present invention, mouse marrow cell micro nuclear test and mouse mirror aberration test result are feminine gender, point out product safety of the present invention.
During product of the present invention 30 days feeding trials, the activity of animal, ingest, the ordinary circumstance such as defecation shows no obvious abnormalities, and the body weight of animal, food-intake, routine blood indexes, organ weights are had no significant effect, when male and female rat high dose group is 20 times that are equivalent to human body recommended amounts, indices Testing index does not all observe ANOMALOUS VARIATIONS.
Human feeding trial is summed up
Function of blood sugar reduction human feeding trial is carried out according to health food assessment technique specification 2012 revised edition, select the state of an illness after diet control or OHA treatment more stable, do not need to change types of drugs and dosage, the adult H patients with type Ⅰ DM patient only taking maintenance dose includes test in, adopt two kinds of control design between self and group, 100 examples are selected to meet the examination trencherman of inclusive criteria, by blood sugar level, sex, age, the course of disease, take kind and be roughly balancedly divided into two groups, often organize 50 examples, be divided into test-meal group and control group at random, take product of the present invention 30 days, health check-up.
Result of the test shows, experimenter took given the test agent after one month, obviously can improve type-II diabetes patient clinical symptom, reduces fasting blood-glucose and 2h-plasma glucose (P < 0.05); Before and after test-meal, the every Testing index of blood, urine, stool and hepatic and renal function is all in normal range (NR), and prompting given the test agent is healthy without obvious damage to experimenter, has auxiliary hyperglycemic effect.
Obviously; the above embodiment of the present invention is only for example of the present invention is clearly described; and be not the restriction to embodiments of the present invention; for those of ordinary skill in the field; can also make other changes in different forms on the basis of the above description; here cannot give exhaustive to all embodiments, every belong to technical scheme of the present invention the apparent change of extending out or variation be still in the row of protection scope of the present invention.
Claims (6)
1. a corn stigma solid beverage, is characterized in that, this corn stigma solid beverage comprises the raw material of following weight parts: Corn silk P.E 10 ~ 60 parts, xylitol 10 ~ 60 parts and steviol glycoside 10 ~ 60 parts.
2. corn stigma solid beverage according to claim 1, is characterized in that, this corn stigma solid beverage also comprises circle luxuriant Cillium 10 ~ 60 parts.
3. corn stigma solid beverage according to claim 1 and 2, it is characterized in that, described Corn silk P.E is prepared by following method: take corn stigma, the aqueous solution adding pH7.0 ~ 7.5 of 5 ~ 20 times of corn stigma weight carries out ultrasonic extraction, the power of ultrasonic extraction is 50 ~ 100w, time is 0.5 ~ 3 hour, filter, collect filtrate, gained filter residue uses the ultrasonic extraction of the aqueous solution of pH8.1 ~ 8.5 of 5 ~ 20 times of corn stigma weight 0.5 ~ 3 hour again, filter, merge and extract gained filtrate, obtain liquid-type Corn silk P.E through reduced pressure concentration; Or, further by described liquid-type Corn silk P.E freezing 24 ~ 36h under-100 ~-50 DEG C of conditions, then at-60 ~-48 DEG C, freeze-drying 36 ~ 72h under air pressure 0.05mbar condition, pulverized 60 mesh sieves, obtain freeze-dried powder, obtain solid type Corn silk P.E.
4. corn stigma solid beverage according to claim 1 and 2, it is characterized in that, described Corn silk P.E is prepared by following method: take corn stigma, the water heating reflux method adding 5 ~ 20 times of corn stigma weight extracts 2 times, each 1h, merge extract, obtain liquid-type corn stigma extract through reduced pressure concentration; Or, further by described liquid-type corn stigma extract freezing 24 ~ 36h under-100 ~-50 DEG C of conditions, then at-60 ~-48 DEG C, freeze-drying 36 ~ 72h under air pressure 0.05mbar condition, pulverized 60 mesh sieves, obtain freeze-dried powder, obtain solid type Corn silk P.E.
5., as claim 1, the preparation method of the corn stigma solid beverage described in the arbitrary claim of 3-4, is characterized in that, the method comprise described Corn silk P.E, xylitol are mixed with steviol glycoside after make particle.
6. the preparation method of the corn stigma solid beverage as described in claim as arbitrary in claim 2-4, is characterized in that, the method comprises makes particle by described Corn silk P.E, the luxuriant Cillium of circle, xylitol after mixing with steviol glycoside.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510732949.5A CN105265985B (en) | 2015-11-03 | 2015-11-03 | A kind of corn stigma solid beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510732949.5A CN105265985B (en) | 2015-11-03 | 2015-11-03 | A kind of corn stigma solid beverage and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105265985A true CN105265985A (en) | 2016-01-27 |
| CN105265985B CN105265985B (en) | 2017-09-29 |
Family
ID=55136491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510732949.5A Active CN105265985B (en) | 2015-11-03 | 2015-11-03 | A kind of corn stigma solid beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105265985B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105767449A (en) * | 2016-04-05 | 2016-07-20 | 荣成市福星海产有限公司 | Natural low-calorie health kelp ice cream powder and preparation method thereof |
| CN107637743A (en) * | 2017-09-28 | 2018-01-30 | 广州白云山星群(药业)股份有限公司 | Sugarless type mulberry leaf granular solids beverage and preparation method thereof |
| CN110916033A (en) * | 2019-11-07 | 2020-03-27 | 南方医科大学 | Beverage for reducing uric acid and preparation method thereof |
| CN111493244A (en) * | 2020-03-29 | 2020-08-07 | 湖南省拜尔艾克斯生物技术有限公司 | Edible plant blood sugar reducing beverage and preparation method thereof |
| CN116211968A (en) * | 2023-03-09 | 2023-06-06 | 青岛康迈臣生物科技有限责任公司 | Hypoglycemic composition, preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1788894C (en) * | 1991-02-27 | 1993-01-15 | Запорожский государственный университет | Non-alcoholic medical and prophylaxis drink |
| CN102551160A (en) * | 2012-02-02 | 2012-07-11 | 徐州林泉绿色食品饮料厂 | Corn silk hpyerglycemic beverage and its preparation method |
| CN103222663A (en) * | 2013-05-22 | 2013-07-31 | 四川省农业科学院农产品加工研究所 | Corn stigma solid beverage and brewing method thereof |
| CN104042958A (en) * | 2014-06-26 | 2014-09-17 | 吉林化工学院 | Semi-bionic extraction method of active component in corn stigma and antioxidation effect of active component |
-
2015
- 2015-11-03 CN CN201510732949.5A patent/CN105265985B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1788894C (en) * | 1991-02-27 | 1993-01-15 | Запорожский государственный университет | Non-alcoholic medical and prophylaxis drink |
| CN102551160A (en) * | 2012-02-02 | 2012-07-11 | 徐州林泉绿色食品饮料厂 | Corn silk hpyerglycemic beverage and its preparation method |
| CN103222663A (en) * | 2013-05-22 | 2013-07-31 | 四川省农业科学院农产品加工研究所 | Corn stigma solid beverage and brewing method thereof |
| CN104042958A (en) * | 2014-06-26 | 2014-09-17 | 吉林化工学院 | Semi-bionic extraction method of active component in corn stigma and antioxidation effect of active component |
Non-Patent Citations (3)
| Title |
|---|
| 李兴广: "《降血压该怎么吃 你必知的100味降压药食通补方》", 31 January 2015 * |
| 赵余庆: "《中药及其天然产物提取制备关键技术》", 31 January 2012 * |
| 陈炜: "玉米须总皂苷提取工艺比较及改善糖尿病并发症的实验研究", 《中国优秀硕士论文电子期刊网》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105767449A (en) * | 2016-04-05 | 2016-07-20 | 荣成市福星海产有限公司 | Natural low-calorie health kelp ice cream powder and preparation method thereof |
| CN107637743A (en) * | 2017-09-28 | 2018-01-30 | 广州白云山星群(药业)股份有限公司 | Sugarless type mulberry leaf granular solids beverage and preparation method thereof |
| CN110916033A (en) * | 2019-11-07 | 2020-03-27 | 南方医科大学 | Beverage for reducing uric acid and preparation method thereof |
| CN111493244A (en) * | 2020-03-29 | 2020-08-07 | 湖南省拜尔艾克斯生物技术有限公司 | Edible plant blood sugar reducing beverage and preparation method thereof |
| CN116211968A (en) * | 2023-03-09 | 2023-06-06 | 青岛康迈臣生物科技有限责任公司 | Hypoglycemic composition, preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105265985B (en) | 2017-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105265985B (en) | A kind of corn stigma solid beverage and preparation method thereof | |
| CN102551065B (en) | Blood sugar reducing food series | |
| CN100998650A (en) | Use of cinnamonum cassia for treating diabetes, its products and preparing method | |
| CN104543834A (en) | Pumpkin powder with blood sugar reducing effect and preparation method thereof | |
| CN104255978A (en) | Functional health green tea beverage using corn silk as main material | |
| CN106901118A (en) | Solid beverage with auxiliary hyperglycemic effect and preparation method thereof | |
| CN105832794A (en) | Application of Gynura procumbens to production of medicine, healthcare food or functional food for preventing and treating hyperuricemia | |
| CN105030984B (en) | A kind of semen litchi health care oral liquid and preparation method with hypoglycemic, tune rouge and alleviation diabetic complication | |
| CN105343585B (en) | A kind of corn stigma effervescent tablet and preparation method thereof | |
| CN102578668B (en) | Beverage for assisting in reducing blood sugar | |
| CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
| CN105341893A (en) | Composition for assisting in reducing blood glucose and application | |
| CN105410580B (en) | A kind of corn stigma effervescent solid beverage and preparation method thereof | |
| CN107343889A (en) | A kind of peacilomyce hepiahi bacterium fermentation culture medium for being used to treat the 1st type or diabetes B | |
| CN104027494B (en) | A kind of Chinese medicine composition with anti-aging and health-care efficacy | |
| CN104255988A (en) | Tea type capsules and production method thereof | |
| CN101843310A (en) | Jiantangcha (blood glucose benefiting tea) capsule for adjunctively reducing blood glucose and improving symptoms of diabetes and preparation method thereof | |
| CN105012826B (en) | A kind of intelligence development leaf extract and preparation method thereof, application | |
| CN101147584B (en) | Health-care food capable of preventing and treating diabetes and preparation method thereof | |
| CN102631494A (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN109350644A (en) | Auxiliary hyperglycemic tablet | |
| CN108403818A (en) | A kind of composition of auxiliary hyperglycemic and application thereof | |
| CN111961560B (en) | Ginger chrysanthemum juice wine and preparation method thereof | |
| CN101444599A (en) | Corn silk extract and preparation method thereof and application thereof in preparing drugs for treating gout | |
| CN103989168B (en) | A kind of hypoglycemic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210621 Address after: 161000 No.01, floor 01, unit 00, south side of Suiman highway, Jianhua District, Qiqihar City, Heilongjiang Province Patentee after: Heilongjiang Beima Biotechnology Co.,Ltd. Address before: 161006 333 Bukuibei Street, Jianhua District, Qiqihar City, Heilongjiang Province Patentee before: QIQIHAR MEDICAL University |